Moreover, in a nicotine-derived nitrosamine ketone model of tobacco-related lung cancer, genetic or pharmacologic blockade of ADAM17 led to a significant reduction of lung lesions and concomitant reduced sIL-6R levels [158]. This evidence concerns the gene IL6R and lung carcinoma.